Literature DB >> 7172508

Radiometric ligand binding assay for C-reactive protein. Complexed C-reactive protein is not detectable in acute phase serum.

F C De Beer, B Shine, M B Pepys.   

Abstract

A radiometric ligand binding assay for human C-reactive protein (CRP) was established using pneumococcal C polysaccharide (CPS) coupled to magnetizable cellulose particles as the solid phase ligand. Competition for binding to the solid phase between 125I-CRP and unlabelled CRP permitted detection of 30 micrograms/l of CRP and the precise assay of concentrations up to 3000 micrograms/l. Identical results were obtained when the assay was used to quantitate isolated pure CRP and pure CRP added to normal human serum. However in vitro addition of known ligands for CRP to acute phase serum resulted in lowering of the apparent CRP concentration in this assay and addition of as little as 1 microgram/l of free CPS or 1 mg/l of lecithin was demonstrable in this way. A combination of the ligand binding assay and the standard electroimmunoassay for CRP was therefore used to test acute phase sera for the presence of CRP complexed in vitro. No evidence of complexed CRP was detected among sera containing between 1-319 mg/l of CRP from patients with Hodgkin's disease (10), rheumatoid arthritis (10), Crohn's disease (19) and various microbial infections (11), including six with subacute bacterial endocarditis. Since it is likely that CRP does form complexes with its ligands in the plasma these results suggest that complexed CRP is rapidly cleared from the circulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7172508      PMCID: PMC1536841     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Isolation of C-reactive protein by affinity chromatography.

Authors:  M B Pepys; A C Dash; M J Ashley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

2.  Isolation of a peptido-polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C-reactive protein and a mouse anti-phosphorylcholine myeloma serum.

Authors:  B A Baldo; T C Fletcher; J Pepys
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

3.  Primary structure of human C-reactive protein.

Authors:  E B Oliveira; E C Gotschlich; T Y Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

4.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  Structural and immunological studies on the pneumococcal C polysaccharide.

Authors:  E C Gotschlich; T Y Liu
Journal:  J Biol Chem       Date:  1967-02-10       Impact factor: 5.157

6.  Antigenic and C-substance activities of related glycopeptides from fungal, parasitic and vegetable sources.

Authors:  J Pepys; J L Longbottom
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

7.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

8.  Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine.

Authors:  L A Potempa; J N Siegel; H Gewurz
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

9.  Interaction of C-reactive protein with artificial phosphatidylcholine bilayers.

Authors:  J E Volanakis; K W Wirtz
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

10.  Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity.

Authors:  K James; B Hansen; H Gewurz
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

View more
  8 in total

1.  C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease.

Authors:  B Shine; J T Bourne; F Begum Baig; J Dacre; D V Doyle
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

2.  Agglutination of intravenous lipid emulsion ('Intralipid') and plasma lipoproteins by C-reactive protein.

Authors:  I R Rowe; A K Soutar; M B Pepys
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

Review 3.  C-reactive protein and the biology of disease.

Authors:  Waliza Ansar; Shyamasree Ghosh
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

4.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

Authors:  D M Vigushin; M B Pepys; P N Hawkins
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  In vivo turnover studies of C-reactive protein and lipoproteins in the rabbit.

Authors:  I F Rowe; M L Baltz; A K Soutar; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

6.  Circulating human C-reactive protein binds very low density lipoproteins.

Authors:  I F Rowe; A K Soutar; I M Trayner; G R Thompson; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

7.  Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins.

Authors:  I F Rowe; A K Soutar; I M Trayner; M L Baltz; F C de Beer; L Walker; D Bowyer; J Herbert; A Feinstein; M B Pepys
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

8.  Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia.

Authors:  Lutfiye Oksuz; Ayper Somer; Nuran Salman; Osman Erk; Nezahat Gurler
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.